AlzeCure Pharma Working Capital to Net Assets Ratio
AlzeCure Pharma working capital to net assets ratio. AlzeCure Pharma (ALZCUR) has a Working Capital to Net Assets ratio of 96.9% as of September 2025. Working capital of Skr49.12 Million (current assets of Skr62.21 Million minus current liabilities of Skr13.09 Million) is measured against net assets of Skr50.66 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check ALZCUR tangible net worth ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of AlzeCure Pharma (2017–2024)
Working capital to net assets ratio of AlzeCure Pharma from 2017 to 2024. This chart shows how AlzeCure Pharma's Working Capital to Net Assets ratio has evolved across 8 annual periods from 2017 to 2024. As of September 2025, the ratio stands at 96.9%, reflecting working capital of Skr49.12 Million against net assets of Skr50.66 Million SEK. See operational self-sufficiency of AlzeCure Pharma to measure how many days the company can operate on defensive assets alone.
AlzeCure Pharma Working Capital to Net Assets Ratio by Year (2017–2024)
AlzeCure Pharma working capital to net assets ratio by year from 2017 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for AlzeCure Pharma from 2017 to 2024, covering 8 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see ALZCUR total assets.
| Year | WC/NA Ratio | Working Capital (SEK) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 99.1% | Skr25.96 Million | Skr26.18 Million | Skr34.21 Million | Skr8.25 Million | ▲ +0.8 pp |
| 2023 | 98.3% | Skr23.38 Million | Skr23.77 Million | Skr31.61 Million | Skr8.23 Million | ▲ +70.0 pp |
| 2022 | 28.4% | Skr17.15 Million | Skr60.48 Million | Skr27.50 Million | Skr10.35 Million | ▼ -67.3 pp |
| 2021 | 95.6% | Skr31.53 Million | Skr32.97 Million | Skr44.20 Million | Skr12.67 Million | ▼ -2.6 pp |
| 2020 | 98.2% | Skr108.79 Million | Skr110.75 Million | Skr115.86 Million | Skr7.07 Million | ▼ -0.8 pp |
| 2019 | 99.0% | Skr180.22 Million | Skr182.01 Million | Skr184.96 Million | Skr4.75 Million | ▼ -0.7 pp |
| 2018 | 99.7% | Skr232.55 Million | Skr233.17 Million | Skr237.16 Million | Skr4.61 Million | ▲ +0.2 pp |
| 2017 | 99.5% | Skr51.56 Million | Skr51.83 Million | Skr55.70 Million | Skr4.15 Million | — |